Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomised, Double-blind Placebo-controlled, Subcutaneous Immunotherapy Clinical Trial With Depigmented and Polymerized Allergen Extract of Olea Europaea Pollen in Patients With Hypersensitivity to Olea Pollen

NCT00831025 is registered in ClinicalTrials.gov with Laboratorios Leti, S.L. as lead sponsor.

NCT NCT00831025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00831025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomised, Double-blind Placebo-controlled, Subcutaneous Immunotherapy Clinical Trial With Depigmented and Polymerized Allergen Extract of Olea Europaea Pollen in Patients With Hypersensitivity to Olea Pollen
Lead sponsor
Laboratorios Leti, S.L.
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2008
Completion date
January 31, 2013
Enrollment
158 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

rhinitis or rhinoconjunctivitis with or without asthma induced by hypersensitivity to olea europea pollen